Cargando…
Probing the Allosteric Modulation of P-Glycoprotein: A Medicinal Chemistry Approach Toward the Identification of Noncompetitive P-Gp Inhibitors
[Image: see text] A medicinal chemistry approach combining in silico and in vitro methodologies was performed aiming at identifying and characterizing putative allosteric drug-binding sites (aDBSs) at the interface of the transmembrane- and nucleotide-binding domains (TMD-NBD) of P-glycoprotein. Two...
Autores principales: | Bonito, Cátia A., Ferreira, Ricardo J., Ferreira, Maria-José. U., Durães, Fernando, Sousa, Emília, Gillet, Jean-Pierre, Cordeiro, M. Natália D. S., dos Santos, Daniel J. V. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061618/ https://www.ncbi.nlm.nih.gov/pubmed/37008154 http://dx.doi.org/10.1021/acsomega.2c08273 |
Ejemplares similares
-
Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity
por: Bonito, Cátia A., et al.
Publicado: (2020) -
P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993) -
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
por: Dewanjee, Saikat, et al.
Publicado: (2017) -
The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar
por: Taylor, J C, et al.
Publicado: (1999) -
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)